VRTX has recorded a positive one-day return after earnings in 58% of instances. When the return is positive, the median ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

Analysts anticipate Vertex Pharmaceuticals to report an earnings per share (EPS) of $4.31. Anticipation surrounds Vertex Pharmaceuticals's announcement, with investors hoping to hear about both ...

The stock's fall snapped a seven-day winning streak.

The new campaign stars former NFL quarterback Alex Smith, whose leg injury during a 2018 game led to a case of ...

Retired NFL quarterback Alex Smith is helping others through the 'taboo' of pain after nearly dying from a leg injury in 2018 ...

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.19% to $509.50 Wednesday, on what proved to be an all-around positive ...

A recent decision from the United States District Court for the District of Columbia continues to give significant deference ...

We expect Vertex Pharmaceuticals Incorporated VRTX to surpass expectations when it reports first-quarter 2025 results on May ...

FOX Sports' Joel Klatt joins Colin Cowherd to dive into what led to Shedeur Sanders dropping to the fifth round and how he ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...